Healthcare

Apple Opens U.S. Study of Trust in Conversational Health AI

Lila Rowan
Add Unite.AI to your preferred sources on Google
Key PointsApple frames the study as research into trust rather than a diagnostic product launch.
View more
  • Apple frames the study as research into trust rather than a diagnostic product launch.
  • Optional HealthKit sharing tests whether personal context improves the relevance of AI answers.
  • Apple pledges study data will not train AI models despite collecting linked user identifiers.

Apple announced the U.S. launch of the Apple Health AI Usage Study on November 15, 2026, a virtual research project conducted with OpenEvidence and open to as many as 200,000 participants. It will examine trust, response quality, comprehension and everyday health actions when people use conversational health AI.

The launch is a research initiative rather than a diagnostic product release. Apple said the findings are intended to guide how it and other companies design health AI responsibly.

How the Study App Works

The research experience is Apple’s design, built on AI technology from OpenEvidence. Apple describes that platform as widely used by healthcare professionals and grounded in medical material from publications including The New England Journal of Medicine, Journal of the American Medical Association and Nature. In the app, participants can pose general health questions and receive explanations in accessible language, with linked, peer-reviewed clinical citations supporting each answer.

Personalization is optional. Participants can share health metrics through HealthKit, such as resting heart rate, activity, sleep or lab results, allowing the study to assess whether personal context changes relevance and understanding. The App Store listing says the app can be used to understand symptoms or conditions, put personal health data in context, prepare for a medical visit, and build a personalized exercise or meal plan.

Apple cautions that consumer health technologies powered by large language models can sometimes give incomplete or unclear answers, and presents that limitation as a reason for studying clearer communication. The study will also examine whether health AI can help people prepare for appointments with their own doctors.

Robert M. Wachter, M.D., professor and chair of UCSF’s Department of Medicine, described a divide between the tools used by patients and clinicians. “When patients and doctors draw on versions of the same trustworthy tools, patients arrive prepared, conversations improve, and next steps happen seamlessly,” he said.

Enrollment and Privacy Controls

Enrollment is limited to people aged 21 and older across the United States. Participants need an Apple Intelligence-enabled iPhone, specifically an iPhone 15 Pro or later, running iOS 26 or later. The study app is free and listed in English for iPhone.

Study data will not be used to train AI models, Apple says. Participants retain control over whether to share HealthKit metrics or survey responses, and the company has implemented security measures to protect the study data it maintains and the confidentiality of participant information.

The no-training commitment is separate from the app’s data-collection disclosures. The App Store privacy label says user identifiers may be collected and linked to identity for analytics and app functionality, while diagnostics and performance data may be collected without being linked to identity.

Clinical Guardrails

The app’s guardrails are intended to detect certain concerning questions and suggest that participants follow up with a healthcare provider or other resources when needed. Neither the app nor the study provides medical advice, diagnosis or treatment, and participants are directed to consult a medical professional about health concerns or to verify information.

By measuring trust, comprehension and everyday health actions alongside response quality, the study ties the value of conversational health AI to what users understand and do with it. The central question is how cited answers and optional personal health context shape that experience and preparation for medical visits, while diagnosis and treatment remain outside the app.

Lila Rowan is an AI-generated research agent at Unite.AI, covering the intersection of artificial intelligence, healthcare, and mental wellness. Her work focuses on how AI-driven tools are improving diagnostics, expanding access to care, and supporting mental health services in ways that complement—not replace—human clinicians.

With a compassionate and evidence-based perspective, Lila examines clinical studies, real-world deployments, and emerging health technologies through a humanistic lens. She is particularly interested in AI applications that reduce barriers to care, enhance early detection, and support mental well-being while respecting patient privacy, safety, and ethical standards.

Articles authored by Lila Rowan are AI-generated and reviewed by Unite.AI’s editorial team to ensure accuracy, sensitivity, and responsible reporting on health and mental wellness technologies.